Nuveen Asset Management, LLC Puma Biotechnology, Inc. Transaction History

Nuveen Asset Management, LLC

$340 Billion
Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 79,101 shares of PBYI stock, worth $230,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,101

Previous 55,922 41.45%

Holding current value

$230,974

Previous $142,000 69.72%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.42 - $3.39 $56,093 - $78,576	23,179 Added 41.45%	79,101 $241,000
Q2 2024 Aug 09, 2024	BUY	$2.92 - $5.83 $163,292 - $326,025	55,922 New	55,922 $182,000
Q2 2022 Aug 15, 2022	SELL	$1.64 - $3.3 $163,322 - $328,637	-99,587 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.13 - $3.24 $55 - $84	26 Added 0.03%	99,587 $308,000
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $27,667 - $63,878	-9,708 Reduced 8.88%	99,561 $283,000
Q3 2021 Nov 12, 2021	SELL	$6.63 - $9.39 $14,155 - $20,047	-2,135 Reduced 1.92%	109,269 $754,000
Q2 2021 Aug 16, 2021	SELL	$8.98 - $11.6 $1.19 Million - $1.54 Million	-132,963 Reduced 54.41%	111,404 $1.02 Million
Q1 2021 May 17, 2021	BUY	$9.38 - $13.63 $965,361 - $1.4 Million	102,917 Added 72.76%	244,367 $2.38 Million
Q4 2020 Feb 16, 2021	BUY	$7.78 - $12.13 $2,077 - $3,238	267 Added 0.19%	141,450 $1.45 Million
Q3 2020 Nov 16, 2020	SELL	$9.5 - $11.14 $2.94 Million - $3.45 Million	-309,957 Reduced 68.71%	141,183 $1.42 Million
Q2 2020 Aug 14, 2020	SELL	$7.01 - $13.24 $198,999 - $375,857	-28,388 Reduced 5.92%	451,140 $4.71 Million
Q1 2020 May 14, 2020	SELL	$6.28 - $14.57 $5.03 Million - $11.7 Million	-800,760 Reduced 62.55%	479,528 $4.05 Million
Q4 2019 Feb 14, 2020	BUY	$6.5 - $10.73 $767,305 - $1.27 Million	118,047 Added 10.16%	1,280,288 $11.2 Million
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $4.86 Million - $7.13 Million	555,116 Added 91.43%	1,162,241 $12.5 Million
Q2 2019 Aug 15, 2019	BUY	$12.3 - $35.76 $7.47 Million - $21.7 Million	607,125 New	607,125 $7.72 Million

Others Institutions Holding PBYI

# of Institutions

110

Shares Held

28.3M

Call Options Held

27.9K

Put Options Held

3.4K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $133M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Puma Biotechnology, Inc. Transaction History